Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Lakota

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|November 21, 2017
Ensuring quality pharmacokinetic analyses in antimicrobial drug development programsElizabeth A Lakota, Justin C Bader, Christopher M Rubino
Antimicrobial Agents and Chemotherapy|March 21, 2018
Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 DataElizabeth A Lakota, Voon Ong, Shawn Flanagan, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2019
Erratum for Lakota et al., "Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data"Elizabeth A Lakota, Voon Ong, Shawn Flanagan, et al.
Journal of Clinical Pharmacology|April 12, 2019
Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons LearnedIslam R Younis, Elizabeth A Lakota, Donna A Volpe, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation SolutionElizabeth A Lakota, Nobuo Sato, Tomokazu Koresawa, et al.
Open Forum Infectious Diseases|December 25, 2018
Time for Precision: A World Without Susceptibility BreakpointsJustin C Bader, Elizabeth A Lakota, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body SizesElizabeth A Lakota, Cornelia B Landersdorfer, Li Zhang, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control AlgorithmElizabeth A Lakota, Cornelia B Landersdorfer, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrataJustin C Bader, Elizabeth A Lakota, Shawn Flanagan, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment <i>In Vitro</i> Infection ModelBrian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|November 21, 2017
Ensuring quality pharmacokinetic analyses in antimicrobial drug development programsElizabeth A Lakota, Justin C Bader, Christopher M Rubino
Antimicrobial Agents and Chemotherapy|March 21, 2018
Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 DataElizabeth A Lakota, Voon Ong, Shawn Flanagan, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2019
Erratum for Lakota et al., "Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data"Elizabeth A Lakota, Voon Ong, Shawn Flanagan, et al.
Journal of Clinical Pharmacology|April 12, 2019
Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons LearnedIslam R Younis, Elizabeth A Lakota, Donna A Volpe, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation SolutionElizabeth A Lakota, Nobuo Sato, Tomokazu Koresawa, et al.
Open Forum Infectious Diseases|December 25, 2018
Time for Precision: A World Without Susceptibility BreakpointsJustin C Bader, Elizabeth A Lakota, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body SizesElizabeth A Lakota, Cornelia B Landersdorfer, Li Zhang, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control AlgorithmElizabeth A Lakota, Cornelia B Landersdorfer, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrataJustin C Bader, Elizabeth A Lakota, Shawn Flanagan, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment <i>In Vitro</i> Infection ModelBrian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Pageof 2